thanks for the insight - this is painful no doubt. Realistically, do you see this as being game over for the co science wise, or do you think these kinks relating to this season's particular attack rate/trial timing can be addressed in a follow up p3 trial? I lost a lot of money today and have no choice but to hold, but I guess I would like to know the ability of the science to re-establish itself here over the next 1-2 years.
spare me. Mgmt was arrogant here and got cocky and it costed SH. They could have shopped this co to the market for 15-20 easy, but stan and his brazen go it alone plan cost us. We now are looking at multiple years, at best, before we return to where we were yesterday share price wise. And our trials are expensive, how are we going to raise money to fund further trials/launch the drugs now? Cannot dillute at these levels and a partnership in this desperate situation would not result in favorable terms for us. We are in a horrible position end of story.